Clinical reduction of serum levels of TNF-α and clinical disease activity scores in rheumatoid arthritis [21] and C-reactive protein (CRP) in Crohn's disease have been reported [22], in response to invasive VNS-devices, which necessitates operative implantation with potential postoperative complications [23]. This evidence concerns the gene TNF and rheumatoid arthritis.